Challenges in diagnosing necrotizing enterocolitis.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 24 8 2021
Statut: ppublish

Résumé

One of the many challenges with necrotizing enterocolitis (NEC) remains our inability to make an accurate diagnosis of NEC. The lack of a unifying cause and multiple variations in presentations lead to great uncertainty with NEC. Separating out the needs of the researcher wanting to define NEC from the clinician and patient family's perspectives who want an accurate diagnosis for NEC is important. The need to augment and/or replace the outdated modified Bell staging criteria is crucial to improving NEC management. Emerging literature suggests that genetic susceptibility and stool microbiota signatures may help identify preterm infants at increased risk of the disease. Ongoing studies using single or multi-omic approaches may help to characterize biomarkers that will aid in the prediction or early diagnosis of NEC, as well as differentiate other causes of severe bowel injury. Bowel ultrasound shows promise in improving our diagnostic accuracy for NEC but has been slow in adoption. Patient family perspectives are key in accelerating our efforts to integrate newer diagnostic methods into practice.

Identifiants

pubmed: 32855507
doi: 10.1038/s41390-020-1090-4
pii: 10.1038/s41390-020-1090-4
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-20

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK117296
Pays : United States

Références

Neu, J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr. Clin. North Am. 43, 409–432 (1996).
doi: 10.1016/S0031-3955(05)70413-2
Bell, M. J. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 187, 1–7 (1978).
doi: 10.1097/00000658-197801000-00001
Battersby, C., Longford, N., Costeloe, K., Modi, N. & Group UKNCNES. Development of a gestational age-specific case definition for neonatal necrotizing enterocolitis. JAMA Pediatr. 171, 256–263 (2017).
doi: 10.1001/jamapediatrics.2016.3633
Gordon, P. V., Swanson, J. R., MacQueen, B. C. & Christensen, R. D. A critical question for NEC researchers: can we create a consensus definition of NEC that facilitates research progress? Semin. Perinatol. 41, 7–14 (2017).
doi: 10.1053/j.semperi.2016.09.013
Caplan, M. S. et al. Necrotizing enterocolitis: using regulatory science and drug development to improve outcomes. J. Pediatr. 212, 208.e1–215.e1 (2019).
Kliegman, R. M. & Fanaroff, A. A. Necrotizing enterocolitis. N. Engl. J. Med. 310, 1093–1103 (1984).
doi: 10.1056/NEJM198404263101707
Berseth, C. L., Bisquera, J. A. & Paje, V. U. Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 111, 529–534 (2003).
doi: 10.1542/peds.111.3.529
Meinzen-Derr, J. et al. Role of human milk in extremely low birth weight infants’ risk of necrotizing enterocolitis or death. J. Perinatol. 29, 57–62 (2009).
doi: 10.1038/jp.2008.117
Neu, J. & Pammi, M. Necrotizing enterocolitis: the intestinal microbiome, metabolome and inflammatory mediators. Semin. Fetal Neonatal Med. 23, 400–405 (2018).
doi: 10.1016/j.siny.2018.08.001
Yee, W. H. et al. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 129, e298–e304 (2012).
doi: 10.1542/peds.2011-2022
Uauy, R. D. et al. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J. Pediatr. 119, 630–638 (1991).
doi: 10.1016/S0022-3476(05)82418-7
Maayan-Metzger, A., Itzchak, A., Mazkereth, R. & Kuint, J. Necrotizing enterocolitis in full-term infants: case-control study and review of the literature. J. Perinatol. 24, 494–499 (2004).
doi: 10.1038/sj.jp.7211135
Li, Q. Y. et al. Differences in the clinical characteristics of early- and late-onset necrotizing enterocolitis in full-term infants: a retrospective case-control study. Sci. Rep. 7, 43042 (2017).
doi: 10.1038/srep43042
Vongbhavit, K. & Underwood, M. A. Intestinal perforation in the premature infant. J. Neonatal Perinat. Med. 10, 281–289 (2017).
doi: 10.3233/NPM-16148
Gordon, P. V. & Attridge, J. T. Understanding clinical literature relevant to spontaneous intestinal perforations. Am. J. Perinatol. 26, 309–316 (2009).
doi: 10.1055/s-0028-1103514
Moorman, J. R. et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J. Pediatr. 159, 900–906 e901 (2011).
doi: 10.1016/j.jpeds.2011.06.044
Fairchild, K. D. et al. Vital signs and their cross-correlation in sepsis and NEC: a study of 1,065 very-low-birth-weight infants in two NICUs. Pediatr. Res. 81, 315–321 (2017).
doi: 10.1038/pr.2016.215
Kliegman, R. M., Walker, W. A. & Yolken, R. H. Necrotizing enterocolitis: research agenda for a disease of unknown etiology and pathogenesis. Pediatr. Res. 34, 701–708 (1993).
doi: 10.1203/00006450-199312000-00001
Wang, K., Tao, G., Sun, Z. & Sylvester, K. G. Recent potential noninvasive biomarkers in necrotizing enterocolitis. Gastroenterol. Res. Pract. 2019, 8413698 (2019).
pubmed: 31178908 pmcid: 6501130
Garg, B. D., Sharma, D. & Bansal, A. Biomarkers of necrotizing enterocolitis: a review of literature. J. Matern. Fetal Neonatal Med. 31, 3051–3064 (2018).
doi: 10.1080/14767058.2017.1361925
Gephart, S. M. et al. Changing the paradigm of defining, detecting, and diagnosing NEC: perspectives on Bell’s stages and biomarkers for NEC. Semin. Pediatr. Surg. 27, 3–10 (2018).
doi: 10.1053/j.sempedsurg.2017.11.002
Goldstein, G. P. & Sylvester, K. G. Biomarker discovery and utility in necrotizing enterocolitis. Clin. Perinatol. 46, 1–17 (2019).
doi: 10.1016/j.clp.2018.10.001
Zani, A. & Pierro, A. Necrotizing enterocolitis: controversies and challenges. F1000Res 4, 1373 (2015).
Bhandari, V. et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117, 1901–1906 (2006).
doi: 10.1542/peds.2005-1414
Cuna, A., George, L. & Sampath, V. Genetic predisposition to necrotizing enterocolitis in premature infants: current knowledge, challenges, and future directions. Semin. Fetal Neonatal Med. 23, 387–393 (2018).
doi: 10.1016/j.siny.2018.08.006
Nino, D. F., Sodhi, C. P. & Hackam, D. J. Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat. Rev. Gastroenterol. Hepatol. 13, 590–600 (2016).
doi: 10.1038/nrgastro.2016.119
Sampath, V. et al. SIGIRR genetic variants in premature infants with necrotizing enterocolitis. Pediatrics 135, e1530–e1534 (2015).
doi: 10.1542/peds.2014-3386
Hartel, C. et al. NOD2 loss-of-function mutations and risks of necrotizing enterocolitis or focal intestinal perforation in very low-birth-weight infants. Inflamm. Bowel Dis. 22, 249–256 (2016).
doi: 10.1097/MIB.0000000000000658
Kim, J. H. Role of abdominal US in diagnosis of NEC. Clin. Perinatol. 46, 119–127 (2019).
doi: 10.1016/j.clp.2018.10.006
Faingold, R. et al. Necrotizing enterocolitis: assessment of bowel viability with color doppler US. Radiology 235, 587–594 (2005).
doi: 10.1148/radiol.2352031718

Auteurs

Jae H Kim (JH)

Division of Neonatology, Perinatal Institute, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA. jae.kim@cchmc.org.

Venkatesh Sampath (V)

Division of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Children's Mercy Research Institute, Kansas City, MO, USA.

Jennifer Canvasser (J)

Necrotizing Enterocolitis (NEC) Society, Davis, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH